Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Milestone Pharmaceuticals Inc (MIST)

8.55   -0.19 (-2.17%) 08-14 16:00
Open: 8.74 Pre. Close: 8.74
High: 8.85 Low: 8.49
Volume: 644,633 Market Cap: 211M
Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for the treatment of atrial fibrillation, angina, and other cardiovascular indications. The company was founded in 2003 and is headquartered in Montral, Canada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.908 - 8.993 8.993 - 9.045
Low: 8.311 - 8.421 8.421 - 8.488
Close: 8.424 - 8.603 8.603 - 8.711

Technical analysis

as of: 2020-08-14 4:32:16 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 13.32     One year: 15.56
Support: Support1: 6.32    Support2: 3.18
Resistance: Resistance1: 11.40    Resistance2: 13.32
Pivot: 8.89
Moving Average: MA(5): 8.89     MA(20): 8.03
MA(100): 4.17     MA(250): 12.91
MACD: MACD(12,26): 1.11     Signal(9): 1.24
Stochastic oscillator: %K(14,3): 35.80     %D(3): 49.66
RSI: RSI(14): 61.23
52-week: High: 24.01  Low: 1.69  Change(%): -52.0
Average Vol(K): 3-Month: 576278  10-Days: 95619

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MIST has closed above bottom band by 30.7%. Bollinger Bands are 63.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to MIST's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 14 Aug 2020
Oppenheimer Sticks to Their Buy Rating for Milestone Pharmaceuticals (MIST) - Smarter Analyst

Wed, 12 Aug 2020
Milestone Pharmaceuticals: 2Q Earnings Snapshot - Houston Chronicle

Wed, 12 Aug 2020
Milestone Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Clinical and Corporate Update - PRNewswire

Mon, 10 Aug 2020
Why Earnings Season Could Be Great for Milestone Pharmaceuticals (MIST) - Yahoo Finance

Thu, 06 Aug 2020
Milestone Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference - PRNewswire

Tue, 04 Aug 2020
How Many Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Shares Do Institutions Own? - Yahoo Finance

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 25
Shares Float (M) 8
% Held by Insiders 6.96
% Held by Institutions 72.43
Shares Short (K) 1,320
Shares Short P. Month (K) 472

Stock Financials

EPS -2.810
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.060
Profit Margin
Operating Margin
Return on Assets (ttm) -43.6
Return on Equity (ttm) -70.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.584
Qtrly Earnings Growth
Operating Cash Flow (M) -55
Levered Free Cash Flow (M) -33

Stock Valuations

PE Ratio -3.04
PEG Ratio
Price to Book value 2.11
Price to Sales
Price to Cash Flow -3.86

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.